| Brian J Gallagher, DO | |
|
1103 W Liberty St, Farmington, MO 63640-1921 | |
| (573) 756-6751 | |
| (573) 756-6807 |
| Full Name | Brian J Gallagher |
|---|---|
| Gender | Male |
| Speciality | Vascular Surgery |
| Experience | 36 Years |
| Location | 1103 W Liberty St, Farmington, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639285356 | NPI | - | NPPES |
| 247857105 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2086S0129X | Surgery - Vascular Surgery | R8J31 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Parkland Health Center | Farmington, MO | Hospital |
| Memorial Hospital | Belleville, IL | Hospital |
| Barnes Jewish Hospital | Saint louis, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Physician Groups Lc | 3072421254 | 409 |
News Archive
Many people with painful, creaky knees and hips find relief after replacing their bad joints with new artificial joints made from titanium. But some of these people develop painful inflammation that can lead to bone destruction and loosening of the new joint. A new study led by researchers at the University of Medicine and Dentistry of New Jersey and published by the Journal of Immunology suggests that tiny titanium particles that flake away from the artificial joints through normal wear and tear may play a direct role in that inflammation.
Female rats avoid males whose great-grandfathers were exposed to a common fruit crop fungicide, preferring instead males whose ancestors were uncontaminated, researchers from The University of Texas at Austin have discovered.
Celiac disease-safe wheat, premature infant pain detection, and new medicines to fight flu and cancer are among the ideas to receive $2.9 million in funding from Washington's Life Sciences Discovery Fund (LSDF).
Between seizures and continually, brain cells in epileptic patients send signals that make "empty memories," perhaps explaining the learning problems faced by up to 40 percent of patients. This is the finding of a study in rats and humans led by researchers at NYU Langone Medical Center and published April 25 in Nature Medicine.
Alkermes plc today announced the initiation of FORWARD-3 and FORWARD-4, two of the three planned phase 3 core efficacy studies in the pivotal clinical program for ALKS 5461, a once-daily, oral investigational medicine with a novel mechanism of action for the adjunctive treatment of major depressive disorder (MDD).
› Verified 1 days ago
| Entity Name | Physician Groups Lc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285664268 PECOS PAC ID: 3072421254 Enrollment ID: O20040220001157 |
News Archive
Many people with painful, creaky knees and hips find relief after replacing their bad joints with new artificial joints made from titanium. But some of these people develop painful inflammation that can lead to bone destruction and loosening of the new joint. A new study led by researchers at the University of Medicine and Dentistry of New Jersey and published by the Journal of Immunology suggests that tiny titanium particles that flake away from the artificial joints through normal wear and tear may play a direct role in that inflammation.
Female rats avoid males whose great-grandfathers were exposed to a common fruit crop fungicide, preferring instead males whose ancestors were uncontaminated, researchers from The University of Texas at Austin have discovered.
Celiac disease-safe wheat, premature infant pain detection, and new medicines to fight flu and cancer are among the ideas to receive $2.9 million in funding from Washington's Life Sciences Discovery Fund (LSDF).
Between seizures and continually, brain cells in epileptic patients send signals that make "empty memories," perhaps explaining the learning problems faced by up to 40 percent of patients. This is the finding of a study in rats and humans led by researchers at NYU Langone Medical Center and published April 25 in Nature Medicine.
Alkermes plc today announced the initiation of FORWARD-3 and FORWARD-4, two of the three planned phase 3 core efficacy studies in the pivotal clinical program for ALKS 5461, a once-daily, oral investigational medicine with a novel mechanism of action for the adjunctive treatment of major depressive disorder (MDD).
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Brian J Gallagher, DO 1103 W Liberty St, Farmington, MO 63640-1921 Ph: (573) 756-6751 | Brian J Gallagher, DO 1103 W Liberty St, Farmington, MO 63640-1921 Ph: (573) 756-6751 |
News Archive
Many people with painful, creaky knees and hips find relief after replacing their bad joints with new artificial joints made from titanium. But some of these people develop painful inflammation that can lead to bone destruction and loosening of the new joint. A new study led by researchers at the University of Medicine and Dentistry of New Jersey and published by the Journal of Immunology suggests that tiny titanium particles that flake away from the artificial joints through normal wear and tear may play a direct role in that inflammation.
Female rats avoid males whose great-grandfathers were exposed to a common fruit crop fungicide, preferring instead males whose ancestors were uncontaminated, researchers from The University of Texas at Austin have discovered.
Celiac disease-safe wheat, premature infant pain detection, and new medicines to fight flu and cancer are among the ideas to receive $2.9 million in funding from Washington's Life Sciences Discovery Fund (LSDF).
Between seizures and continually, brain cells in epileptic patients send signals that make "empty memories," perhaps explaining the learning problems faced by up to 40 percent of patients. This is the finding of a study in rats and humans led by researchers at NYU Langone Medical Center and published April 25 in Nature Medicine.
Alkermes plc today announced the initiation of FORWARD-3 and FORWARD-4, two of the three planned phase 3 core efficacy studies in the pivotal clinical program for ALKS 5461, a once-daily, oral investigational medicine with a novel mechanism of action for the adjunctive treatment of major depressive disorder (MDD).
› Verified 1 days ago
Mr. Steven L Kurzweil, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1103 W Liberty St, Farmington, MO 63640 Phone: 636-344-2101 | |
Jeffrey Swinarski, Surgery Medicare: Accepting Medicare Assignments Practice Location: 1103 W Liberty St, Farmington, MO 63640 Phone: 573-756-6751 Fax: 573-756-6807 | |
Dr. William C Sippo, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 1101 Weber Rd, Suite 205, Farmington, MO 63640 Phone: 573-756-8400 Fax: 573-756-8403 |